Gastroesophageal reflux disease management according to contemporary international guidelines: A translational study

World Journal of Gastroenterology

Volumn 17, Issue 9, 2011, Pages 1160-1166

  Pace, Fabio ^a   Riegler, Gabriele ^b   De Leone, Annalisa ^c   Dominici, Patrizia ^a   Grossi, Enzo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Bracco Imaging SpA   (Italy)

Author keywords

Gastroesophageal reflux disease; Nonerosive gastroesophageal reflux; Proton pump inhibitors; Quality of life; Questionnaire

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COUGHING; DRUG MEGADOSE; DYSPHAGIA; ESOPHAGITIS; ESOPHAGUS MUCOSA; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HOARSENESS; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NON EROSIVE REFLUX DISEASE; POPULATION; PRACTICE GUIDELINE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REFERENCE VALUE; STANDARD; THORAX PAIN; TRANSLATIONAL RESEARCH; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 79955931910     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i9.1160     Document Type: Article

References (20)

1. An evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut 1999; 44 Suppl 2: S1-S166
2. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004; 53 Suppl 4: iv1-IV24
3. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920; quiz 1943
4. Pace F, Buscema M, Dominici P, Intraligi M, Baldi F, Cestari R, Passaretti S, Bianchi Porro G, Grossi E. Artificial neural networks are able to recognize gastro-oesophageal reflux disease patients solely on the basis of clinical data. Eur J Gastroenterol Hepatol 2005; 17: 605-610
5. Dupuy HJ. The Psychological General Well-being (PGWB) Index. In: Wenger NK, Mattson ME, Furburg CD, Elinson J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq Publishing, 1984: 170-183
6. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-547
7. Savary M, Miller G. The esophagus: handbook and atlas of endoscopy. Solothurn (Switzerland): Verlag Gassman, 1978: 119-159
8. Fass R, Ofman JJ, Sampliner RE, Camargo L, Wendel C, Fennerty MB. The omeprazole test is as sensitive as 24-h oesophagealpH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis.Aliment Pharmacol Ther 2000; 14: 389-396
9. Fass R, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE, Fennerty MB. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999; 159: 2161-2168
10. Ofman JJ Gralnek IM, Udani J, Fennerty MB, Fass R. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med 1999; 107: 219-227
11. Bate CM, Riley SA, Chapman RW, Durnin AT, Taylor MD. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999; 13: 59-66
12. Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1998; 33: 15-20
13. Metz DC, Childs ML, Ruiz C, Weinstein GS. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997; 116: 41-46
14. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, Schrijver M, Dieleman LA, Meuwissen SG. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997; 92: 1997-2000
15. Grossi E, Mosconi P, Groth N, Niero M, Apolone G. IL Questionario Psychological General Well Being. Questionario per la valutazione dello stato generale di benessere psicologico. Versione Italiana. Istituto di Ricerche Farmacologiche Mario Negri, Milan. 2002
16. Juul-Hansen P, Rydning A. Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice? Scand J Gastroenterol 2003; 38: 1200-1203
17. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004; 140: 518-527
18. Galmiche JP, Clouse RE, Bálint A, Cook IJ, Kahrilas PJ, Paterson WG, Smout AJ. Functional esophageal disorders. Gastroenterology 2006; 130: 1459-1465
19. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 656-664
20. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Malfertheiner P, Stolte M, Willich SN. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the Pro GERD initiative. Aliment Pharmacol Ther 2003; 18: 767-776